Mounjaro: A New Hope for Weight Loss and Diabetes Management in India
In a significant move for healthcare in India, Eli Lilly has launched Mounjaro, a revolutionary injectable drug designed to tackle obesity and type 2 diabetes. This much-anticipated drug is priced at INR 3,500 for a 2.5 mg vial and INR 4,375 for a 5 mg vial. It promises to be a game-changer for millions struggling with weight-related health issues.
What is Mounjaro? Mounjaro, also known as Tirzepatide, is a once-a-week prescription medication. It helps regulate appetite, reduce food intake, and decrease body weight.
The drug works by activating both GIP and GLP-1 hormone receptors. These receptors play a crucial role in managing blood sugar levels and fat utilization. This dual action makes Mounjaro particularly effective for chronic weight management and improving glycemic control in adults with type 2 diabetes.
Why is This Launch Important?
India has the second-highest number of people with diabetes in the world, around 100 million. Obesity is a major risk factor for diabetes. It is connected to more than 200 health problems, including high blood pressure and heart disease. The arrival of Mounjaro gives new hope to people dealing with these issues
Also Read: New Hope for Cancer Patients! Zydus Lifesciences’ Apalutamide Tablets Approved by USFDA
Clinical Trials and Results
Mounjaro has been tested in two major global studies: SURMOUNT-1 and SURPASS. In the SURMOUNT-1 trial, people who took Mounjaro lost a lot of weight. At the highest dose, they lost an average of 21.8 kg. The SURPASS trials showed that Mounjaro also helps control blood sugar levels, which is very important for people with diabetes.
Commitment to India
Eli Lilly has set special prices for India to make sure more people can get this treatment. Winselow Tucker, who leads Lilly in India, said the company wants to work with the government and others to help people understand and manage obesity and diabetes better.
The launch of Mounjaro in India marks a significant step in addressing obesity and diabetes. With its proven results and affordable pricing, Mounjaro will help many people improve their health.
Also Read: Shilpa Medicare’s Stock Rises 10% on Cancer Therapy Deal with mAbTree
